Palomino Laboratories Holds Annual Shareholder Meeting

• Palomino Laboratories shareholders approved an amendment to the 2025 Equity Incentive Plan at their November 5, 2026 annual meeting.
• The amendment sets reserved shares at the greater of 10,000,000 or 15% of issued and outstanding common stock on an as-converted basis.
• It also clarifies that increases under this provision do not require a separate plan amendment.
• Shareholders elected Jeffrey B. Shealy, Steven P. DenBaars and Richard Ogawa to the board.
• They also ratified KNAV CPA LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Palomino Laboratories Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-050300), on November 06, 2026, and is solely responsible for the information contained therein.